Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin

Organisation Organisation Roche (Group)
Products Product Tecentriq®
  Product 2 clinical research
Person Person Horning, Sandra (Roche 201401–201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19)
     


   
Record changed: 2018-05-27

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Roche (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top